Roche’s executives, including CMO (Chief Medical Officer) Levi Garraway, claimed in a recorded video conference with staff acquired by Swiss Newspaper Blick, that the company is planning to slash 300 to 400 jobs at PD (Product Development) locations, this year.
Roche has a global workforce of 101,000 employees. The Basel-based corporation has acknowledged the video conversation and stated that the company will cooperate with all the staff members and assist them to cope with the loss of their jobs.
The company operates product development locations in Switzerland, United Kingdom, China, United States, and Canada, and other locations, where personnel’s responsibilities include clinical investigations for potential pharmaceuticals developed under many research programs.
Project delivery, project management, coaching, learning and development, administrative support, and business management are among the jobs that are affected as a result of employees cut down, stated by Roche’s manager in a video conference.
From August through October, workers who are about to lose their jobs will be notified, with British employees being notified first then the workers in other locations. In the Video, an HR (Human Resources) manager claimed that their duties will end in early November.
“This is the hardest thing I’ve had to do since I’ve been in Roche,” Head of global drug safety, Felix Arellano, said on the recording.
In 2020, Roche reported a net profit of $16.3 billion (15.1 billion Swiss francs), boosted by pandemic diagnostics that helped to overcome the declining medicine sales